Bioavailability of magnesium from different pharmaceutical formulations

Urological Research

Volumn 39, Issue 2, 2011, Pages 123-127

  Siener, Roswitha ^a   Jahnen, Andrea ^a   Hesse, Albrecht ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bioavailability; Hypomagnesuria; Magnesium oxide; Magnesium supplementation; Serum magnesium; Urinary magnesium excretion

Indexed keywords

MAGNESIUM OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG EXCRETION; DRUG FORMULATION; DRUG URINE LEVEL; EFFERVESCENT TABLET; HUMAN; LONG TERM CARE; MAGNESIUM URINE LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; URINARY EXCRETION; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CALCIUM OXALATE; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; HUMANS; INTESTINAL ABSORPTION; MAGNESIUM; MAGNESIUM OXIDE; MALE; TABLETS; UROLITHIASIS; YOUNG ADULT;

EID: 79955731606     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-010-0309-y     Document Type: Article

References (24)

1. R Siener N Schade C Nicolay GE von Unruh A Hesse 2005 The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients J Urol 173 1601 1605 15821507 10.1097/01.ju.0000154626.16349.d3 1:CAS:528:DC%2BD2MXjtFals70%3D (Pubitemid 40524783)
2. Hesse A, Tiselius HG, Siener R, Hoppe B (2009) Urinary stones: diagnosis, treatment, and prevention of recurrence. 3rd revised and enlarged edition. Karger, Basel
3. MK Li NJ Blacklock J Garside 1985 Effects of magnesium on calcium oxalate crystallization J Urol 133 123 125 3964871 1:CAS:528:DyaL2MXmtVeisQ%3D%3D (Pubitemid 15195767)
4. JF Desmars R Tawashi 1973 Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH Biochim Biophys Acta 313 256 267 4741585 1:CAS:528:DyaE3sXkvFShtLw%3D
5. S Voss DJ Zimmermann A Hesse GE von Unruh 2004 The effect of oral administration of calcium and magnesium on intestinal oxalate absorption in humans Isotopes Environ Health Stud 40 199 205 15370283 10.1080/ 10256010410001671609 1:CAS:528:DC%2BD2cXnt1amtL4%3D (Pubitemid 39259840)
6. M Liebman G Costa 2000 Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads J Urol 163 1565 1569 10751889 10.1016/S0022-5347(05)67680-X 1:CAS:528:DC%2BD3cXivFOhsL0%3D (Pubitemid 30226328)
7. DJ Zimmermann S Voss GE von Unruh A Hesse 2005 Importance of magnesium in absorption and excretion of oxalate Urol Int 74 262 267 15812215 10.1159/000083560 1:CAS:528:DC%2BD2MXivFKjtbw%3D (Pubitemid 41201540)
8. I Melnick RR Landes AA Hoffman JF Burch 1971 Magnesium therapy for recurring calcium oxalate urinary calculi J Urol 105 119 122 5543051 1:STN:280:DyaE3M7gvVyitQ%3D%3D
9. EL Prien SF Gershoff 1974 Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi J Urol 112 509 512 4414543
10. G Johansson U Backman BG Danielson B Fellström S Ljunghall B Wikström 1982 Effects of magnesium hydroxide in renal stone disease J Am Coll Nutr 1 179 185 6764473 1:STN:280:DyaL3s3pt1SitQ%3D%3D
11. DR Wilson AL Strauss MA Manuel 1984 Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis Urol Res 12 39 40
12. B Ettinger JT Citron B Livermore LI Dolman 1988 Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not J Urol 139 679 684 3280829 1:STN:280:DyaL1c7nt1Kgug%3D%3D
13. MS Pearle CG Roehrborn CYC Pak 1999 Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis J Endourol 13 679 685 10608521 10.1089/end.1999.13.679 1:STN:280:DC%2BD3c%2FnsVagsQ%3D%3D
14. HG Tiselius C Ahlstrand L Larsson 1980 Urine composition in patients with urolithiasis during treatment with magnesium oxide Urol Res 8 197 200 7222314 10.1007/BF00256993 1:STN:280:DyaL3M7nvVChsA%3D%3D (Pubitemid 11203744)
15. Tiselius HG, Alken P, Buck C, Gallucci M, Knoll T, Sarica K, Türk C (2009) Guidelines on urolithiasis. European Association of Urology, The Netherlands
16. M Firoz M Graber 2001 Bioavailability of US commercial magnesium preparations Magnes Res 14 257 262 11794633 1:CAS:528:DC%2BD38XktlKisA%3D%3D
17. JS Lindberg MM Zobitz JR Poindexter CYC Pak 1990 Magnesium bioavailability from magnesium citrate and magnesium oxide J Am Coll Nutr 9 48 55 2407766 1:CAS:528:DyaK3cXksFOrsbg%3D
18. B Mühlbauer M Schwenk WM Coram KH Antonin P Etienne PR Bieck FL Douglas 1991 Magnesium-l-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers Eur J Clin Pharmacol 40 437 438 2050185 10.1007/BF00265863
19. AF Walker G Marakis S Christie M Byng 2003 Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study Magnes Res 16 183 191 14596323 1:CAS:528:DC%2BD2cXnsFWrtrc%3D (Pubitemid 37386916)
20. 28Mg in man Metab Clin Exp 9 646 659 1:CAS:528:DyaF3cXhtF2rtr4%3D
21. GA Quamme 1993 Magnesium homeostasis and renal magnesium handling Miner Electrolyte Metab 19 218 225 8264507 1:CAS:528:DyaK2cXitFehtrY%3D (Pubitemid 23353324)
22. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung (German, Austrian and Swiss Societies of Nutrition) (2000) Referenzwerte für die Nährstoffzufuhr (Reference values for nutrient intake). Umschau Braus, Frankfurt
23. R Siener A Jahnen A Hesse 2004 Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization Eur J Clin Nutr 58 270 276 14749747 10.1038/sj.ejcn. 1601778 1:CAS:528:DC%2BD2cXntlegug%3D%3D (Pubitemid 38256581)
24. R Siener A Hesse 1995 Influence of a mixed and a vegetarian diet on urinary magnesium excretion and concentration Brit J Nutr 73 783 790 7626596 10.1079/BJN19950081 1:CAS:528:DyaK2MXlvVOksLs%3D